Monster Beverage's (MNST) Growth Strategies Good: Apt to Hold
https://www.zacks.com/stock/news/2261572/monster-beverage-s-mnst-growth-strategies-good-apt-to-hold?cid=CS-ZC-FT-analyst_blog|rank_focused-2261572
Apr 24, 2024 - Monster Beverage (MNST) gains from strength in its energy drinks category and product innovations.
0
"Bad News" is Good News for these 3 Stocks
https://www.zacks.com/commentary/2261466/bad-news-is-good-news-for-these-3-stocks?cid=CS-ZC-FT-investment_ideas-2261466
Apr 24, 2024 - Stocks often bottom on poor news. Investors should focus on the reaction to the news instead of the news itself.
0
Boeing Mixed in Q1, TMO Beats; Durable Goods In-Line
https://www.zacks.com/stock/news/2261364/boeing-mixed-in-q1-tmo-beats-durable-goods-in-line?cid=CS-ZC-FT-ahead_of_wall_street-2261364
Apr 24, 2024 - Boeing posted a slimmer loss per share while Thermo Fisher outperformed. Durable Goods performed as expected.
0
Ducks ‘in a good spot’ to compete for a playoff spot next season
https://www.ocregister.com/2024/04/23/ducks-in-a-good-spot-to-compete-for-a-playoff-spot-next-season/
Apr 23, 2024 - New leadership and a youth movement endured an injury-plagued season to set a course toward snapping the franchise’s playoff drought, and there is salary cap space to help deploy a more formidable group in 2024-25.
0
Alto Neuroscience schizophrenia treatment shows good phase 1 results
https://seekingalpha.com/news/4092696-alto-neuroscience-schizophrenia-treatment-shows-good-phase-1-results?source=feed_sector_healthcare
Apr 23, 2024 - ALTO-101, a PDE4 inhibitor by Alto Neuroscience, shows promising results in phase 1 trial for cognitive impairment associated with schizophrenia. Read more here.
0
Snap-On: A Good Buy Post The Recent Correction
https://seekingalpha.com/article/4685167-snap-on-a-good-buy-post-the-recent-correction?source=feed_all_articles
Apr 22, 2024 - Snap-on revenues are expected to recover with easing year-over-year comparisons and strategic adjustments in the Tools segment. See why SNA stock is rated buy.
0
PFIX: Good Product But Risky Part Of Cycle
https://seekingalpha.com/article/4685032-pfix-good-product-but-risky-part-of-cycle?source=feed_tag_etf_portfolio_strategy
Apr 22, 2024 - PFIX is constructed with a significant position in over-the-counter interest rate options. Check out the pros and cons of investing in PFIX ETF.
0
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
https://www.cnbc.com/2024/04/20/weight-loss-drug-patients-spend-less-on-restaurants-takeout-survey.html
Apr 20, 2024 - The findings add to concerns that GLP-1s could take a bite out of the bottom lines of some of the biggest restaurant companies and packaged food makers.
0
SPY: Higher For Longer Could Be Good News
https://seekingalpha.com/article/4684840-spy-higher-for-longer-could-be-good-news?source=feed_all_articles
Apr 19, 2024 - Foreign central banks, continuing to buy US Treasuries amid concerns on rising debt, supports economic growth and equity markets like S&P 500. Read more here.
0
Huntington Beach home with radiant heated floors, good feng shui seeks $7.7M
https://www.ocregister.com/2024/04/19/huntington-beach-home-with-radiant-heated-floors-good-feng-shui-seeks-7-7m/
Apr 19, 2024 - The house that sold last in 2017 had half as many bedrooms and bathrooms as the 5,500-square-foot house currently for sale.
0